Dickkopf-related protein 1 (20-29)

Dickkopf-related protein 1

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: ta-320

Synonyms/Alias:Dickkopf-related protein 1 (20-29)

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
Sequence
ALGGHPLLGV
Areas of Interest
Antigen-presenting Cells; Cancer Research

Dickkopf-related protein 1 (20-29) is a synthetic peptide fragment derived from the Dickkopf-1 (DKK1) protein, a well-characterized antagonist of the Wnt signaling pathway. Spanning amino acids 20 to 29 of the full-length DKK1, this peptide segment is of significant interest for researchers investigating the structural and functional domains responsible for modulating cellular signaling. By isolating a defined region of DKK1, the peptide provides a focused tool for dissecting the molecular interactions and biological activities attributed to this critical modulator of cell differentiation, proliferation, and embryonic development. Its use supports advanced studies in developmental biology, cancer research, and the broader field of signal transduction.

Peptide structure-activity relationship studies: The 20-29 fragment of DKK1 is frequently employed in investigations aimed at elucidating the minimal functional motifs responsible for Wnt pathway inhibition. By comparing the biological activity of this segment to other regions or the full-length protein, researchers can map critical residues involved in receptor binding and antagonistic function. Such studies enhance the understanding of peptide-receptor interactions and drive the rational design of novel peptide-based modulators for probing cellular signaling pathways.

Receptor binding assays: The peptide serves as a valuable probe in binding studies targeting the low-density lipoprotein receptor-related proteins 5 and 6 (LRP5/6), which are coreceptors in the Wnt signaling cascade. By employing the 20-29 sequence in competitive binding assays, scientists can quantify affinity, evaluate specificity, and delineate interaction sites between DKK1-derived peptides and their cellular targets. These assays provide mechanistic insight into the inhibition of Wnt signaling and inform the development of molecular tools for pathway modulation.

Peptide-based inhibitor development: As a defined sequence from the functionally significant N-terminal region of DKK1, the 20-29 peptide offers a template for the synthesis and optimization of peptide-based inhibitors. Medicinal chemistry and chemical biology groups utilize this fragment to generate analogs with altered sequences, stability, or binding properties, facilitating the exploration of structure-activity relationships and the identification of lead compounds for further research applications in cell signaling.

Biochemical pathway analysis: The fragment is incorporated into in vitro and cell-based assays to assess its capacity to modulate Wnt pathway activity. By introducing the peptide into cultured cells or biochemical systems, researchers can monitor downstream effects on gene expression, protein phosphorylation, or other signaling events. These experiments help clarify the contribution of specific DKK1 domains to pathway regulation and support the dissection of complex signaling networks in developmental and disease contexts.

Antibody generation and epitope mapping: The defined amino acid sequence of the 20-29 peptide enables its use as an immunogen for raising sequence-specific antibodies or as a standard in epitope mapping studies. By generating antibodies that recognize this discrete region, scientists can develop sensitive detection tools for tracking DKK1 expression, localization, or post-translational modifications. Such reagents are essential for the detailed characterization of DKK1 in both basic research and advanced analytical applications.

Source#
Homo sapiens (human)
Epitope
20-29
Restricting HLA
HLA-A2
References
Qian; Blood  2007

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Modification ServicesPeptide Synthesis ServicesPeptide Nucleic Acids SynthesiscGMP Peptide ServiceCustom Conjugation ServiceEpitope Mapping ServicesPeptide Analysis ServicesPeptide CDMO
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers